Canadian researchers have reported three cases involving patients who underwent blood transfusions in order to qualify as participants for trials of new cancer drugs. The researchers have expressed concern over the practice, citing the risks associated with transfusions, and are recommending that all other options -- such as using anemia treatments -- be exhausted first before resorting to blood transfusions.

Related Summaries